drugset

drugset / Trial / NCT05667077

The Effect of Amantadine on Post-COVD-19 Fatigue

NCT05667077 ↗

Phase 2 Unknown 83 enrolled Shahid Beheshti University of Medical Sciences

RandomizedParallel-groupOpen-labelTreatment

Summary

This study aimed to investigate amantadine's safety and its effect on reducing post-COVID-19 fatigue.

Timeline

Start: 2022-12-26
Primary completion: 2022-12-29
Completion: 2023-01-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Amantadine	Unknown	100 mg	Oral

Indications